'When I put mascara on it looks like I have false lashes': This £6 bestselling eyelash growth serum with over 6,800 five-star reviews is finally back in stock

SHOPPING — Contains affiliated content. Products featured in this Mail Best article are selected by our shopping writers. If you make a purchase using links on this page, Dailymail.co.uk will earn an affiliate commission. Click here for more information.

When it comes to the best eyelash growth serum on the market, the Eclat Eyelash Growth Serum is adored by Amazon shoppers, but it has been sold out for months, with many fans starting to speculate it had been discontinued. The good news? It's finally back in stock and on sale for £5.69.

That's right, the vegan and cruelty-free eyelash serum hailed as the 'best eyelash serum' is back, and according to Amazon shoppers, it's a 'must have' whether you want to get longer lashes the natural way or bring extension-damaged eyelashes back to life.

Eclat Eyelash Growth Serum 

The number one bestselling Eclat Eyelash Growth Serum is blended with natural ingredients, including growth-stimulating peptides and conditioning pro-vitamin B5 to increase lash length, thickness, and fullness.

The brand claims that more than 94 per cent of users saw rapid growth, and 89 per cent had fuller lashes within a six-week clinical study. 

£5.69 (save £2.30) Shop
Back in stock: The number one bestselling Eclat Eyelash Growth Serum is on sale for just £5.69

Back in stock: The number one bestselling Eclat Eyelash Growth Serum is on sale for just £5.69 

Now on sale for just £5.69 (was £7.99), more than 6,800 beauty lovers have given the eyelash growth serum a perfect five-star rating, earning it the number one bestselling spot in Amazon's Eyelash Treatments category.

Shoppers, many of whom have shared impressive before and after photos, call the vegan-friendly and cruelty-free eyelash serum 'the best' they've used and describe the change in the length of their lashes as 'remarkable'.

'I have been using this religiously for the past two weeks,' one five-star reviewer explained. 'And as you can see, they have become thicker longer and they curl easier.

'When I put mascara on it looks like I have false lashes I'm also very sensitive around the eyes this has not given me any sort of reaction it also smells amazing!'

'My eyelashes are usually thin, short and virtually non-existent, so I have to wear mascara all the time,' a second shopper wrote. 

'I still do wear a good moisturising mascara, but this serum has lengthened my lashes so much that when I put mascara on, my lashes actually look LONG and THICKER, and they now curl beautifully with the aid of my eyelash curlers.'

The Eclat Eyelash Growth Serum is blended with natural ingredients, including growth-stimulating peptides and conditioning pro-vitamin B5 to increase lash length, thickness, and fullness

The Eclat Eyelash Growth Serum is blended with natural ingredients, including growth-stimulating peptides and conditioning pro-vitamin B5 to increase lash length, thickness, and fullness

They added: 'So I can safely say that my lashes are longer than they have ever been in my whole life. I will always buy this stuff now, it's organic, and it works. The holy grail of eyelash lengtheners has been found. HURRAH!'

While the Eclat Eyelash Growth Serum's formula shows plenty of potential, you'll have to be patient and consistent to see results. It's worth noting, however, that some reviewers say they see a difference in their lashes in as little as a few days.

Rather than a chemical-filled formula, the Eclat Eyelash Growth Serum is blended with natural ingredients, including growth-stimulating peptides and conditioning pro-vitamin B5 to increase lash length, thickness, and fullness.

The brand claims that more than 94 per cent of users saw rapid growth, and 89 per cent had fuller lashes within a six-week clinical study. 

The comments below have not been moderated.

The views expressed in the contents above are those of our users and do not necessarily reflect the views of MailOnline.

We are no longer accepting comments on this article.